SPONSORED: UBS – U.K. life sciences real estate outlook

The global pandemic accelerated a real estate niche that was already growing at a fast clip: life sciences. And the mismatch between supply and demand of space in the United Kingdom, strong risk-adjusted returns and the rental growth potential have attracted notice by institutional investors. But the sector is nuanced, as are the tenants’ space requirements. In a Q&A published in the February issue of Institutional Real Estate Europe, UBS Asset Management’s Real Estate & Private Markets (REPM) life sciences experts Jonathan Hollick, Olivia Drew and Zachary Gauge discuss the sector’s dynamics and give an outlook into what the next few years might look like for investors. To access a pdf of the Sponsored Section, click here.